TP53 and Leigh syndrome: Additionally, collected data suggest that these widely presented cells, with an inactive MMR pathway, are characteristic of the epithelium in LS patients [38] and can acquire somatic mutations in TP53 or CTNNB1 and, thus, rapidly initiate tumorigenesis [37,39,40].